Company intelligence / Profile preview

Odix Medical

Ownership: Private
Development stage: Commercial

Overview

Odix Medical is developing LumbaCure®, an AR and AI-based medical device designed to revolutionize the treatment of chronic low back pain through active spinal mobilization in a seated position. The device aims to improve both physical and psychological aspects of recovery, with clinical data suggesting a 50% increase in positive patient response rates during rehabilitation. Pivotal clinical studies are underway, with commercial launch planned for late 2026[2].

Therapeutic areas: OtherNeurology
Modalities: DeviceDigital therapeutic (AR/AI-based rehabilitation device)
Industry: Digital Health Medical Devices

Partnerships

Supported by SPW Wallonia DGO6 funding[2]

Beyond the preview

Go deeper on Odix Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Odix Medical.

Explore the full profile